Tag: Insulin pump
Insulet sees momentum, raises outlook
May 7, 2026HME News Staff
ACTON, Mass. – Insulet reported revenue of $761.7 million for the first quarter of 2026, an increase of 33.9% over the prior year. Total Omnipod revenue was $758.4 million, up 36.9%. Of that, U.S. Omnipod revenue was $515.6 million and international Omnipod revenue was $242.9 million.
“We started the year strong, delivering continued growth momentum and robust operating margin expansion in the first quarter,” said Ashley McEvoy, president and CEO. “Our team executed on...
CMS misses mark for CGMs, insulin pumps
April 24, 2026Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Including continuous glucose monitors (CGMs) and insulin pumps in the next round of Medicare’s competitive bidding program overlooks how they are used and will not result in savings to the Medicare program, providers say.
Bundled CGM payments shift upfront costs and risk to suppliers
Currently, Medicare typically pays a one-time amount for CGM receivers, along with a monthly allowance for sensors, transmitters and other disposable supplies. Under the next round...
Med Supplies Council launches impact survey
February 19, 2026HME News Staff
WASHINGTON – AAHomecare’s Medical Supplies Council has launched a nationwide Market Impact Survey to assess the ongoing effects of reimbursement levels, supply chain volatility, product and operational costs, and staffing pressures across a variety of disposable supplies as well as CGMs and insulin infusion pumps.
Product categories included in survey
Ostomy supplies
Urological supplies
Continuous...
In brief: Medicare comparison legislation, Omnipod expansion, Owlet partnership
February 18, 2026HME News Staff
WASHINGTON — Senator Tim Scott, R-S.C., has introduced the Apples to Apples Comparison Act of 2026, which seeks to require the Centers for Medicare and Medicaid Services (CMS) to provide seniors with clear, comparable data when choosing between Medicare Advantage (MA) and traditional fee-for-service coverage. By giving seniors accurate cost and coverage information, the legislation empowers them to choose the plan that best meets their health care needs. “Seniors...
Portal Diabetes achieves Breakthrough designation from FDA for implantable insulin pump
February 17, 2026HME News Staff
WESTFIELD, Ind. – Portal Diabetes has received Breakthrough Device Designation by the Food and Drug Administration (FDA) for its implantable insulin pump system called Portal Pump, and the start of a Phase 1 study on its proprietary temperature-stable insulin, Portal Insulin. The company aims to deliver a functional cure to type 1 diabetes – an implantable insulin pump leveraging the physiologic delivery of insulin to the abdomen, modern continuous glucose monitoring...
Stakeholders build foundation for bid delay legislation
February 13, 2026Theresa Flaherty, Managing Editor
WASHINGTON – Industry stakeholders are working behind the scenes on the introduction of two separate bills that would delay competitive bidding for continuous glucose monitors (CGMs), insulin pumps, and ostomy and urological supplies.
The current plan is to delay CGMs and insulin pumps in one bill, and ostomy and urological supplies in a second bill – a logical split of the product categories, says Jay Witter, vice president of government...
Medtronic builds pharmacy channel for MiniMed insulin pump
January 12, 2026HME News Staff
MINNEAPOLIS – Medtronic Diabetes has expanded U.S. pharmacy formulary access for its MiniMed 780F insulin pump through agreements with major pharmacy benefit managers (PBMs) and group purchasing organizations (GPOs), including Ascent and Zinc.
These agreements also include access to the company's expanded CGM portfolio – Simplera sensor, Simplera Sync sensor, and Instinct sensor, made by Abbott – and build...
Diabetes advocates rally for Medicare reform on insulin pump access
September 26, 2025Theresa Flaherty, Managing Editor
SAN DIEGO – Diabetes stakeholders will meet with CMS in October to urge the agency to update its National Coverage Determination (NCD) guidance on who qualifies for an insulin pump to better reflect current clinical practice.
CMS currently requires a low C-peptide level for insulin pump coverage, which excludes many people with Type 2 diabetes from obtaining an automated insulin delivery (AID) system, even if they were already been benefiting from the technology prior to moving to...
Study: Tandem’s AID can lower A1c in certain Type 2 diabetes patients
September 18, 2025HME News Staff
SAN DIEGO – Tandem Diabetes Care’s Control-IQ+ automated insulin delivery system can lower HbA1c’s in adults with insulin-treated Type 2 diabetes, according to a new study published in the American Diabetes Association’s Diabetes Care. The study, "Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level," is a sub-analysis from the 2IQP randomized, controlled trial. Of the 319 participants in the 2IQP trial, 254 were included...
Pump up the superpower: Insulet, Marvel launch comic hero with Type 1 diabetes
September 12, 2025Tracy Orzel
ACTON, Mass. – Strapping on an insulin pump may not always feel heroic, but Insulet and Marvel are changing that narrative with a new comic that puts a character with Type 1 diabetes at the center of the story.
“At Insulet, we know representation matters and it has a direct impact on how kids and teens embrace diabetes technology,” said Lucas Escobar, the company’s director of U.S. consumer marketing. “That belief drove us to collaborate with Marvel, one of...